Roche Diagnostics International Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Roche Diagnostics International Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012211
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory information, workflow and data management software; and instruments and reagents for life science research. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. It has operations in the Americas, Asia Pacific, Africa, the Middle East and Europe. Roche Diagnostics manages all the central functions of the Diagnostics business of F. Hoffmann-La Roche Ltd and is headquartered in Rotkreuz, Switzerland.

Roche Diagnostics International Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Roche Diagnostics International Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Inotrem Enters into Research Agreement with Roche Diagnostics 11
Eli Lilly Enters into Agreement with Roche Diagnostics International 12
Molecular Devices Enters into Co-Development Agreement with Roche Diagnostics 13
Advanced Biological Labs Extends Co-Promotion Agreement with Roche Diagnostics 14
AUT University Forms Joint Venture with Roche Diagnostics 15
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 16
Advanced Biological Labs And Roche Diagnostics Enter Into Agreement To Promote Sequencing, Genotyping And Drug Resistance Products 17
Roche Diagnostics Enters Into Research Agreement With Vall d’Hebron Institute, CIBE-Rehd And Advanced Biological Labs 18
Acquisition 20
Roche Diagnostics Acquires Genia for up to USD350 Million 20
Roche Diagnostics International Ltd – Key Competitors 21
Roche Diagnostics International Ltd – Key Employees 22
Roche Diagnostics International Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Corporate Communications 25
Apr 13, 2016: Stand Up To Cancer Launches “Catalyst,” a New Research Program Supported by Industry 25
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Roche Diagnostics International Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Roche Diagnostics International Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Inotrem Enters into Research Agreement with Roche Diagnostics 11
Eli Lilly Enters into Agreement with Roche Diagnostics International 12
Molecular Devices Enters into Co-Development Agreement with Roche Diagnostics 13
Advanced Biological Labs Extends Co-Promotion Agreement with Roche Diagnostics 14
AUT University Forms Joint Venture with Roche Diagnostics 15
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 16
Advanced Biological Labs And Roche Diagnostics Enter Into Agreement To Promote Sequencing, Genotyping And Drug Resistance Products 17
Roche Diagnostics Enters Into Research Agreement With Vall d’Hebron Institute, CIBE-Rehd And Advanced Biological Labs 18
Roche Diagnostics Acquires Genia for up to USD350 Million 20
Roche Diagnostics International Ltd, Key Competitors 21
Roche Diagnostics International Ltd, Key Employees 22
Roche Diagnostics International Ltd, Other Locations 23
Roche Diagnostics International Ltd, Subsidiaries 23
Roche Diagnostics International Ltd, Joint Venture 24

★海外企業調査レポート[Roche Diagnostics International Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emami Limited:戦略・SWOT・企業財務分析
    Emami Limited - Strategy, SWOT and Corporate Finance Report Summary Emami Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Northbridge Financial Corporation:企業の戦略的SWOT分析
    Northbridge Financial Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Dan Hotels Corporation Ltd:戦略・SWOT・企業財務分析
    Dan Hotels Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Dan Hotels Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • HSS Engineers Berhad (HSSEB):企業の財務・戦略的SWOT分析
    HSS Engineers Berhad (HSSEB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Otto Bock HealthCare GmbH:企業の戦略的SWOT分析
    Otto Bock HealthCare GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Michigan Public Power Agency:企業の戦略的SWOT分析
    Michigan Public Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Proximus plc:企業の戦略・SWOT・財務分析
    Proximus plc - Strategy, SWOT and Corporate Finance Report Summary Proximus plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Wake Forest Innovations-製薬・医療分野:企業M&A・提携分析
    Summary Wake Forest Innovations (Wake Forest), a subsidiary of Wake Forest Baptist Medical Center, is an enterprise that advances the development and commercialization of discoveries; services; and products such as medicines and vaccines, from the Medical Center and Wake Forest University. The compa …
  • Merz Pharma GmbH & Co KgaA-医療機器分野:企業M&A・提携分析
    Summary Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company’s products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous …
  • Premiere Global Services, Inc.:企業の戦略的SWOT分析
    Premiere Global Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Dialog Group Bhd (DIALOG):企業の財務・戦略的SWOT分析
    Dialog Group Bhd (DIALOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Transaero Inc:企業の戦略・SWOT・財務情報
    Transaero Inc - Strategy, SWOT and Corporate Finance Report Summary Transaero Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kentucky Power Co:企業の戦略的SWOT分析
    Kentucky Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • APL Co Pte Ltd:企業の戦略的SWOT分析
    APL Co Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Olympus Corporation:企業のM&A・事業提携・投資動向
    Olympus Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Olympus Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Kuwait Petroleum International Ltd:企業の戦略的SWOT分析
    Kuwait Petroleum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Weight Watchers International, Inc. (WW):企業の財務・戦略的SWOT分析
    Weight Watchers International, Inc. (WW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Fujirebio Europe NV:企業の戦略的SWOT分析
    Fujirebio Europe NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Ballast Nedam NV:企業の戦略・SWOT・財務情報
    Ballast Nedam NV - Strategy, SWOT and Corporate Finance Report Summary Ballast Nedam NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dermira Inc (DERM):製薬・医療:M&Aディール及び事業提携情報
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆